Global Heart Failure Therapeutics Market Insights and Forecast to 2026
- BMR3911198
- 151 Pages
- June 2020
- Healthcare
Market Analysis and Insights: Global Heart Failure Therapeutics Market
Prior to COVID-19, the market for Heart Failure Therapeutics was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Heart Failure Therapeutics is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Heart Failure Therapeutics market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Heart Failure Therapeutics market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Heart Failure Therapeutics industry.
Global Heart Failure Therapeutics Scope and Segment
Heart Failure Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Heart Failure Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Bayer
Cynokinetics
Les Laboratoires Servier
Merck & Co.
Novartis
Procoralan
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Orion Corporation
PhaseBio Pharmaceuticals
Market Segment by Product Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Heart Failure Therapeutics Breakdown Data by Type
Diagnosis
Prognosis
Treatment Options and Treatment Algorithm
Heart Failure Therapeutics Breakdown Data by Application
Hospital
Clinic
Medical Research Organization
Regional and Country-level Analysis
The Heart Failure Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Heart Failure Therapeutics market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Heart Failure Therapeutics Market Share Analysis
1.1 Heart Failure Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Heart Failure Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Heart Failure Therapeutics Market Size Growth Rate by Type
1.4.2 Diagnosis
1.4.3 Prognosis
1.4.4 Treatment Options and Treatment Algorithm
1.5 Market by Application
1.5.1 Global Heart Failure Therapeutics Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Medical Research Organization
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Heart Failure Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Heart Failure Therapeutics Revenue 2015-2026
2.1.2 Global Heart Failure Therapeutics Sales 2015-2026
2.2 Global Heart Failure Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Heart Failure Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Heart Failure Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Heart Failure Therapeutics Competitor Landscape by Players
3.1 Heart Failure Therapeutics Sales by Manufacturers
3.1.1 Heart Failure Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Heart Failure Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Heart Failure Therapeutics Revenue by Manufacturers
3.2.1 Heart Failure Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Heart Failure Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Heart Failure Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Heart Failure Therapeutics Revenue in 2019
3.2.5 Global Heart Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Heart Failure Therapeutics Price by Manufacturers
3.4 Heart Failure Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Heart Failure Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Heart Failure Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Heart Failure Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Heart Failure Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Heart Failure Therapeutics Sales by Type (2015-2020)
4.1.2 Global Heart Failure Therapeutics Revenue by Type (2015-2020)
4.1.3 Heart Failure Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Heart Failure Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Heart Failure Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Heart Failure Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Heart Failure Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Heart Failure Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Heart Failure Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Heart Failure Therapeutics Sales by Application (2015-2020)
5.1.2 Global Heart Failure Therapeutics Revenue by Application (2015-2020)
5.1.3 Heart Failure Therapeutics Price by Application (2015-2020)
5.2 Heart Failure Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Heart Failure Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Heart Failure Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Heart Failure Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Heart Failure Therapeutics by Country
6.1.1 North America Heart Failure Therapeutics Sales by Country
6.1.2 North America Heart Failure Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Heart Failure Therapeutics Market Facts & Figures by Type
6.3 North America Heart Failure Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Heart Failure Therapeutics by Country
7.1.1 Europe Heart Failure Therapeutics Sales by Country
7.1.2 Europe Heart Failure Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Heart Failure Therapeutics Market Facts & Figures by Type
7.3 Europe Heart Failure Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Heart Failure Therapeutics by Region
8.1.1 Asia Pacific Heart Failure Therapeutics Sales by Region
8.1.2 Asia Pacific Heart Failure Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Heart Failure Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Heart Failure Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Heart Failure Therapeutics by Country
9.1.1 Latin America Heart Failure Therapeutics Sales by Country
9.1.2 Latin America Heart Failure Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Heart Failure Therapeutics Market Facts & Figures by Type
9.3 Central & South America Heart Failure Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Heart Failure Therapeutics by Country
10.1.1 Middle East and Africa Heart Failure Therapeutics Sales by Country
10.1.2 Middle East and Africa Heart Failure Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Heart Failure Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Heart Failure Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Heart Failure Therapeutics Products Offered
11.1.5 Bayer Related Developments
11.2 Cynokinetics
11.2.1 Cynokinetics Corporation Information
11.2.2 Cynokinetics Description and Business Overview
11.2.3 Cynokinetics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cynokinetics Heart Failure Therapeutics Products Offered
11.2.5 Cynokinetics Related Developments
11.3 Les Laboratoires Servier
11.3.1 Les Laboratoires Servier Corporation Information
11.3.2 Les Laboratoires Servier Description and Business Overview
11.3.3 Les Laboratoires Servier Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Les Laboratoires Servier Heart Failure Therapeutics Products Offered
11.3.5 Les Laboratoires Servier Related Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Description and Business Overview
11.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co. Heart Failure Therapeutics Products Offered
11.4.5 Merck & Co. Related Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description and Business Overview
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Heart Failure Therapeutics Products Offered
11.5.5 Novartis Related Developments
11.6 Procoralan
11.6.1 Procoralan Corporation Information
11.6.2 Procoralan Description and Business Overview
11.6.3 Procoralan Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Procoralan Heart Failure Therapeutics Products Offered
11.6.5 Procoralan Related Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Corporation Information
11.7.2 Bristol-Myers Squibb Company Description and Business Overview
11.7.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Company Heart Failure Therapeutics Products Offered
11.7.5 Bristol-Myers Squibb Company Related Developments
11.8 Cardiorentis AG
11.8.1 Cardiorentis AG Corporation Information
11.8.2 Cardiorentis AG Description and Business Overview
11.8.3 Cardiorentis AG Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Cardiorentis AG Heart Failure Therapeutics Products Offered
11.8.5 Cardiorentis AG Related Developments
11.9 CVie Therapeutics Limited
11.9.1 CVie Therapeutics Limited Corporation Information
11.9.2 CVie Therapeutics Limited Description and Business Overview
11.9.3 CVie Therapeutics Limited Sales, Revenue and Gross Margin (2015-2020)
11.9.4 CVie Therapeutics Limited Heart Failure Therapeutics Products Offered
11.9.5 CVie Therapeutics Limited Related Developments
11.10 Orion Corporation
11.10.1 Orion Corporation Corporation Information
11.10.2 Orion Corporation Description and Business Overview
11.10.3 Orion Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Orion Corporation Heart Failure Therapeutics Products Offered
11.10.5 Orion Corporation Related Developments
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Heart Failure Therapeutics Products Offered
11.1.5 Bayer Related Developments
11.12 Market Segment by Product Type
11.12.1 Market Segment by Product Type Corporation Information
11.12.2 Market Segment by Product Type Description and Business Overview
11.12.3 Market Segment by Product Type Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Market Segment by Product Type Products Offered
11.12.5 Market Segment by Product Type Related Developments
11.13 B-Blockers
11.13.1 B-Blockers Corporation Information
11.13.2 B-Blockers Description and Business Overview
11.13.3 B-Blockers Sales, Revenue and Gross Margin (2015-2020)
11.13.4 B-Blockers Products Offered
11.13.5 B-Blockers Related Developments
11.14 Calcium Channel Blockers
11.14.1 Calcium Channel Blockers Corporation Information
11.14.2 Calcium Channel Blockers Description and Business Overview
11.14.3 Calcium Channel Blockers Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Calcium Channel Blockers Products Offered
11.14.5 Calcium Channel Blockers Related Developments
11.15 Cardiac Glycosides
11.15.1 Cardiac Glycosides Corporation Information
11.15.2 Cardiac Glycosides Description and Business Overview
11.15.3 Cardiac Glycosides Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Cardiac Glycosides Products Offered
11.15.5 Cardiac Glycosides Related Developments
11.16 Diuretics
11.16.1 Diuretics Corporation Information
11.16.2 Diuretics Description and Business Overview
11.16.3 Diuretics Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Diuretics Products Offered
11.16.5 Diuretics Related Developments
11.17 Morphine
11.17.1 Morphine Corporation Information
11.17.2 Morphine Description and Business Overview
11.17.3 Morphine Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Morphine Products Offered
11.17.5 Morphine Related Developments
11.18 Vasodilators/Nitrates
11.18.1 Vasodilators/Nitrates Corporation Information
11.18.2 Vasodilators/Nitrates Description and Business Overview
11.18.3 Vasodilators/Nitrates Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Vasodilators/Nitrates Products Offered
11.18.5 Vasodilators/Nitrates Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Heart Failure Therapeutics Market Estimates and Projections by Region
12.1.1 Global Heart Failure Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Heart Failure Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Heart Failure Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Heart Failure Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Heart Failure Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Heart Failure Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Heart Failure Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Heart Failure Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Heart Failure Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Heart Failure Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Heart Failure Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Heart Failure Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Heart Failure Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Heart Failure Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Heart Failure Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Heart Failure Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Heart Failure Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Heart Failure Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Heart Failure Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Heart Failure Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Heart Failure Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Heart Failure Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Heart Failure Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Heart Failure Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Heart Failure Therapeutics Market Segments
Table 2. Ranking of Global Top Heart Failure Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Heart Failure Therapeutics Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diagnosis
Table 5. Major Manufacturers of Prognosis
Table 6. Major Manufacturers of Treatment Options and Treatment Algorithm
Table 7. Global Heart Failure Therapeutics Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Heart Failure Therapeutics Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Heart Failure Therapeutics Sales by Regions 2015-2020 (K Units)
Table 10. Global Heart Failure Therapeutics Sales Market Share by Regions (2015-2020)
Table 11. Global Heart Failure Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Heart Failure Therapeutics Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Heart Failure Therapeutics Sales Share by Manufacturers (2015-2020)
Table 14. Global Heart Failure Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Heart Failure Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Therapeutics as of 2019)
Table 16. Heart Failure Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Heart Failure Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Heart Failure Therapeutics Price (2015-2020) (USD/Unit)
Table 19. Heart Failure Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Heart Failure Therapeutics Product Type
Table 21. Date of International Manufacturers Enter into Heart Failure Therapeutics Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Heart Failure Therapeutics Sales by Type (2015-2020) (K Units)
Table 24. Global Heart Failure Therapeutics Sales Share by Type (2015-2020)
Table 25. Global Heart Failure Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Heart Failure Therapeutics Revenue Share by Type (2015-2020)
Table 27. Heart Failure Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Heart Failure Therapeutics Sales by Application (2015-2020) (K Units)
Table 29. Global Heart Failure Therapeutics Sales Share by Application (2015-2020)
Table 30. North America Heart Failure Therapeutics Sales by Country (2015-2020) (K Units)
Table 31. North America Heart Failure Therapeutics Sales Market Share by Country (2015-2020)
Table 32. North America Heart Failure Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Heart Failure Therapeutics Revenue Market Share by Country (2015-2020)
Table 34. North America Heart Failure Therapeutics Sales by Type (2015-2020) (K Units)
Table 35. North America Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 36. North America Heart Failure Therapeutics Sales by Application (2015-2020) (K Units)
Table 37. North America Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 38. Europe Heart Failure Therapeutics Sales by Country (2015-2020) (K Units)
Table 39. Europe Heart Failure Therapeutics Sales Market Share by Country (2015-2020)
Table 40. Europe Heart Failure Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Heart Failure Therapeutics Revenue Market Share by Country (2015-2020)
Table 42. Europe Heart Failure Therapeutics Sales by Type (2015-2020) (K Units)
Table 43. Europe Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 44. Europe Heart Failure Therapeutics Sales by Application (2015-2020) (K Units)
Table 45. Europe Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Heart Failure Therapeutics Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Heart Failure Therapeutics Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Heart Failure Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Heart Failure Therapeutics Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Heart Failure Therapeutics Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Heart Failure Therapeutics Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 54. Latin America Heart Failure Therapeutics Sales by Country (2015-2020) (K Units)
Table 55. Latin America Heart Failure Therapeutics Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Heart Failure Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Heart Failure Therapeutics Revenue Market Share by Country (2015-2020)
Table 58. Latin America Heart Failure Therapeutics Sales by Type (2015-2020) (K Units)
Table 59. Latin America Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 60. Latin America Heart Failure Therapeutics Sales by Application (2015-2020) (K Units)
Table 61. Latin America Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Heart Failure Therapeutics Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Heart Failure Therapeutics Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Heart Failure Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Heart Failure Therapeutics Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Heart Failure Therapeutics Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Heart Failure Therapeutics Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Major Businesses
Table 72. Bayer Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Bayer Product
Table 74. Bayer Recent Development
Table 75. Cynokinetics Corporation Information
Table 76. Cynokinetics Description and Major Businesses
Table 77. Cynokinetics Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Cynokinetics Product
Table 79. Cynokinetics Recent Development
Table 80. Les Laboratoires Servier Corporation Information
Table 81. Les Laboratoires Servier Description and Major Businesses
Table 82. Les Laboratoires Servier Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Les Laboratoires Servier Product
Table 84. Les Laboratoires Servier Recent Development
Table 85. Merck & Co. Corporation Information
Table 86. Merck & Co. Description and Major Businesses
Table 87. Merck & Co. Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Merck & Co. Product
Table 89. Merck & Co. Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Major Businesses
Table 92. Novartis Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Product
Table 94. Novartis Recent Development
Table 95. Procoralan Corporation Information
Table 96. Procoralan Description and Major Businesses
Table 97. Procoralan Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Procoralan Product
Table 99. Procoralan Recent Development
Table 100. Bristol-Myers Squibb Company Corporation Information
Table 101. Bristol-Myers Squibb Company Description and Major Businesses
Table 102. Bristol-Myers Squibb Company Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bristol-Myers Squibb Company Product
Table 104. Bristol-Myers Squibb Company Recent Development
Table 105. Cardiorentis AG Corporation Information
Table 106. Cardiorentis AG Description and Major Businesses
Table 107. Cardiorentis AG Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Cardiorentis AG Product
Table 109. Cardiorentis AG Recent Development
Table 110. CVie Therapeutics Limited Corporation Information
Table 111. CVie Therapeutics Limited Description and Major Businesses
Table 112. CVie Therapeutics Limited Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. CVie Therapeutics Limited Product
Table 114. CVie Therapeutics Limited Recent Development
Table 115. Orion Corporation Corporation Information
Table 116. Orion Corporation Description and Major Businesses
Table 117. Orion Corporation Heart Failure Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Orion Corporation Product
Table 119. Orion Corporation Recent Development
Table 120. PhaseBio Pharmaceuticals Corporation Information
Table 121. PhaseBio Pharmaceuticals Description and Major Businesses
Table 122. PhaseBio Pharmaceuticals Heart Failure Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. PhaseBio Pharmaceuticals Product
Table 124. PhaseBio Pharmaceuticals Recent Development
Table 125. Market Segment by Product Type Corporation Information
Table 126. Market Segment by Product Type Description and Major Businesses
Table 127. Market Segment by Product Type Heart Failure Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Market Segment by Product Type Product
Table 129. Market Segment by Product Type Recent Development
Table 130. B-Blockers Corporation Information
Table 131. B-Blockers Description and Major Businesses
Table 132. B-Blockers Heart Failure Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. B-Blockers Product
Table 134. B-Blockers Recent Development
Table 135. Calcium Channel Blockers Corporation Information
Table 136. Calcium Channel Blockers Description and Major Businesses
Table 137. Calcium Channel Blockers Heart Failure Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Calcium Channel Blockers Product
Table 139. Calcium Channel Blockers Recent Development
Table 140. Cardiac Glycosides Corporation Information
Table 141. Cardiac Glycosides Description and Major Businesses
Table 142. Cardiac Glycosides Heart Failure Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Cardiac Glycosides Product
Table 144. Cardiac Glycosides Recent Development
Table 145. Diuretics Corporation Information
Table 146. Diuretics Description and Major Businesses
Table 147. Diuretics Heart Failure Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Diuretics Product
Table 149. Diuretics Recent Development
Table 150. Morphine Corporation Information
Table 151. Morphine Description and Major Businesses
Table 152. Morphine Heart Failure Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Morphine Product
Table 154. Morphine Recent Development
Table 155. Vasodilators/Nitrates Corporation Information
Table 156. Vasodilators/Nitrates Description and Major Businesses
Table 157. Vasodilators/Nitrates Heart Failure Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Vasodilators/Nitrates Product
Table 159. Vasodilators/Nitrates Recent Development
Table 160. Global Heart Failure Therapeutics Sales Forecast by Regions (2021-2026) (K Units)
Table 161. Global Heart Failure Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 162. Global Heart Failure Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 163. Global Heart Failure Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 164. North America: Heart Failure Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 165. North America: Heart Failure Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Europe: Heart Failure Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 167. Europe: Heart Failure Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Asia Pacific: Heart Failure Therapeutics Sales Forecast by Region (2021-2026) (K Units)
Table 169. Asia Pacific: Heart Failure Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 170. Latin America: Heart Failure Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 171. Latin America: Heart Failure Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Middle East and Africa: Heart Failure Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 173. Middle East and Africa: Heart Failure Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 175. Key Challenges
Table 176. Market Risks
Table 177. Main Points Interviewed from Key Heart Failure Therapeutics Players
Table 178. Heart Failure Therapeutics Customers List
Table 179. Heart Failure Therapeutics Distributors List
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Heart Failure Therapeutics Product Picture
Figure 2. Global Heart Failure Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Diagnosis Product Picture
Figure 4. Prognosis Product Picture
Figure 5. Treatment Options and Treatment Algorithm Product Picture
Figure 6. Global Heart Failure Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Medical Research Organization
Figure 10. Heart Failure Therapeutics Report Years Considered
Figure 11. Global Heart Failure Therapeutics Market Size 2015-2026 (US$ Million)
Figure 12. Global Heart Failure Therapeutics Sales 2015-2026 (K Units)
Figure 13. Global Heart Failure Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Heart Failure Therapeutics Sales Market Share by Region (2015-2020)
Figure 15. Global Heart Failure Therapeutics Sales Market Share by Region in 2019
Figure 16. Global Heart Failure Therapeutics Revenue Market Share by Region (2015-2020)
Figure 17. Global Heart Failure Therapeutics Revenue Market Share by Region in 2019
Figure 18. Global Heart Failure Therapeutics Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Heart Failure Therapeutics Revenue in 2019
Figure 20. Heart Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Figure 22. Global Heart Failure Therapeutics Sales Market Share by Type in 2019
Figure 23. Global Heart Failure Therapeutics Revenue Market Share by Type (2015-2020)
Figure 24. Global Heart Failure Therapeutics Revenue Market Share by Type in 2019
Figure 25. Global Heart Failure Therapeutics Market Share by Price Range (2015-2020)
Figure 26. Global Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Figure 27. Global Heart Failure Therapeutics Sales Market Share by Application in 2019
Figure 28. Global Heart Failure Therapeutics Revenue Market Share by Application (2015-2020)
Figure 29. Global Heart Failure Therapeutics Revenue Market Share by Application in 2019
Figure 30. North America Heart Failure Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Heart Failure Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Heart Failure Therapeutics Sales Market Share by Country in 2019
Figure 33. North America Heart Failure Therapeutics Revenue Market Share by Country in 2019
Figure 34. U.S. Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Heart Failure Therapeutics Market Share by Type in 2019
Figure 39. North America Heart Failure Therapeutics Market Share by Application in 2019
Figure 40. Europe Heart Failure Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Heart Failure Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Heart Failure Therapeutics Sales Market Share by Country in 2019
Figure 43. Europe Heart Failure Therapeutics Revenue Market Share by Country in 2019
Figure 44. Germany Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Heart Failure Therapeutics Market Share by Type in 2019
Figure 55. Europe Heart Failure Therapeutics Market Share by Application in 2019
Figure 56. Asia Pacific Heart Failure Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Heart Failure Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Heart Failure Therapeutics Sales Market Share by Region in 2019
Figure 59. Asia Pacific Heart Failure Therapeutics Revenue Market Share by Region in 2019
Figure 60. China Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Heart Failure Therapeutics Market Share by Type in 2019
Figure 83. Asia Pacific Heart Failure Therapeutics Market Share by Application in 2019
Figure 84. Latin America Heart Failure Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Heart Failure Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Heart Failure Therapeutics Sales Market Share by Country in 2019
Figure 87. Latin America Heart Failure Therapeutics Revenue Market Share by Country in 2019
Figure 88. Mexico Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Heart Failure Therapeutics Market Share by Type in 2019
Figure 95. Latin America Heart Failure Therapeutics Market Share by Application in 2019
Figure 96. Middle East and Africa Heart Failure Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Heart Failure Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Heart Failure Therapeutics Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Heart Failure Therapeutics Revenue Market Share by Country in 2019
Figure 100. Turkey Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Heart Failure Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Heart Failure Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Heart Failure Therapeutics Market Share by Type in 2019
Figure 107. Middle East and Africa Heart Failure Therapeutics Market Share by Application in 2019
Figure 108. North America Heart Failure Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Heart Failure Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Heart Failure Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Heart Failure Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Heart Failure Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Heart Failure Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Heart Failure Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Heart Failure Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Heart Failure Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Heart Failure Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
